This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Elucid is also pursuing an indication for FFRCT, uniquely derived from its PlaqueIQ technology, to non-invasively measure coronary blockages and the extent of ischemia. Andrew Miller Bio Miller is a healthtechnology veteran with an acumen for transforming startups and growth-stage companies into mature organizations.
Gary Rothenberg, Chief Medical Officer of Podimetrics talks about how healthcare technology can help support a focus on social determinants of health (SDoH) to enhance the relationship between the patient and physician/care team. Dr. Rothenberg: I mentioned risk stratification before. AI has a specific role to play here.
Transparency practices at the FDA: A barrier to global health. Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on HealthTechnology Assessments. 2022 Aug 5;377(6606):572-574. Epub ahead of print. Curr Oncol. 2022 Aug 16;29(8):5774-5791.
Artair Rogers is a first-year doctoral student in the Department of Social and Behavioral Sciences at the Harvard School of Public Health pursuing a PhD in Population HealthSciences. . The post Harms and Biases Associated with the Social Determinants of HealthTechnology Movement appeared first on Bill of Health.
We asked 22 healthcare and healthsciences leaders for their thoughts; here’s what they said. There is an opportunity to adopt and scale the use of innovative care delivery models, team-based care, and healthtechnology solutions to drive efficiency and alleviate clinician burnout by improving clinical workflows.
This brings up the concept of wearable digital healthtechnologies for monitoring. Barker, PhD, MD , Chief Science Officer, Masimo Corporation, Professor Emeritus of Anesthesiology, University of Arizona HealthSciences Jannicke Mellin-Olsen, MD, DPH , Past President, World Federation of Societies of Anesthesiologists Philip D.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content